Prognostic impact of hypoxia-inducible miRNA-210 in patients with lung adenocarcinoma

Journal of Oncology

Volumn 2015, Issue , 2015, Pages

  Osugi, Jun ^a   Kimura, Yuka ^a   Owada, Yuki ^a   Inoue, Takuya ^a   Watanabe, Yuzuru ^a   Yamaura, Takumi ^a   Fukuhara, Mitsuro ^a   Muto, Satoshi ^a   Okabe, Naoyuki ^a   Matsumura, Yuki ^a   Hasegawa, Takeo ^a   Yonechi, Athushi ^a   Hoshino, Mika ^a   Higuchi, Mitsunori ^a   Shio, Yutaka ^a   Suzuki, Hiroyuki ^a   Gotoh, Mitsukazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYPOXIA INDUCIBLE FACTOR; MICRORNA 210;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION;

EID: 84924218599     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2015/316745     Document Type: Article

References (45)

1. B. Keith and M. C. Simon, "Hypoxia-inducible factors, stem cells, and cancer," Cell, vol. 129, no. 3, pp. 465-472, 2007.
2. G. L. Semenza and G. L. Wang, "A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation," Molecular and Cellular Biology, vol. 12, no. 12, pp. 5447-5454, 1992.
3. G. L. Semenza, "Targeting HIF-1 for cancer therapy," Nature Reviews Cancer, vol. 3, no. 10, pp. 721-732, 2003.
4. A. Weidemann and R. S. Johnson, "Biology of HIF-1α;," Cell Death and Differentiation, vol. 15, no. 4, pp. 621-627, 2008.
5. A. Giatromanolaki, M. I. Koukourakis, E. Sivridis et al., "Relation of hypoxia inducible factor 1α; and 2α; in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival," British Journal of Cancer, vol. 85, no. 6, pp. 881-890, 2001.
6. D. E. B. Swinson, J. L. Jones, G. Cox, D. Richardson,A.L.Harris, and K. J. OByrne, "Hypoxia-inducible factor-1α; in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways," International Journal of Cancer, vol. 111, no. 1, pp. 43-50, 2004.
7. S. K. Lau, P. C. Boutros,M. Pintilie et al., "Three-geneprognostic classifier for early-stage non-small-cell lung cancer," Journal of Clinical Oncology, vol. 25, no. 35, pp. 5562-5569, 2007.
8. T. Yohena, I. Yoshino, T. Takenaka et al., "Upregulation of hypoxia-inducible factor-1α;mRNA and its clinical significance in non-small cell lung cancer," Journal ofThoracic Oncology, vol. 4, no. 3, pp. 284-290, 2009.
9. L. M. Greenberger, I. D. Horak, D. Filpula et al., "ARNA antagonist of hypoxia-inducible factor-1α;, EZN-2968, inhibits tumor cell growth," Molecular Cancer Therapeutics, vol. 7, no. 11, pp. 3598-3608, 2008.
10. J. J. Jacoby, B. Erez, M.V.Korshunova et al., "Treatment with hif- 1α antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice," Journal ofThoracic Oncology, vol. 5, no. 7, pp. 940-949, 2010.
11. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function," Cell, vol. 116, no. 2, pp. 281-297, 2004.
12. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, "Identification of novel genes coding for small expressedRNAs," Science, vol. 294, no. 5543, pp. 853-858, 2001.
13. N. C. Lau, L. P. Lim, E. G. Weinstein, and D. P. Bartel, "An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans," Science, vol. 294, no. 5543, pp. 858-862, 2001.
14. R. C. Lee and V. Ambros, "An extensive class of small RNAs in Caenorhabditis elegans," Science, vol. 294, no. 5543, pp. 862-864, 2001.
15. R. Kulshreshtha, M. Ferracin, S. E.Wojcik et al., "A microRNA signature of hypoxia,"Molecular and Cellular Biology, vol. 27,no. 5, pp. 1859-1867, 2007.
16. W. C. S. Cho, A. S. C. Chow, and J. S. K. Au, "Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation," European Journal of Cancer, vol. 45, no. 12, pp. 2197-2206, 2009.
17. E. Miko, Z. Czimmerer, E. Cs̈anky et al., "Differentially expressed micrornas in small cell lung cancer," Experimental Lung Research, vol. 35, no. 8, pp. 646-664, 2009.
18. M. Raponi, L. Dossey, T. Jatkoe et al., "MicroRNA classifiers for predicting prognosis of squamous cell lung cancer," Cancer Research, vol. 69, no. 14, pp. 5776-5783, 2009.
19. S. Volinia, G. A. Calin, C.-G. Liu et al., "A microRNA expression signature of human solid tumors defines cancer gene targets," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
20. N. Yanaihara, N. Caplen, E. Bowman et al., "Unique microRNA molecular profiles in lung cancer diagnosis and prognosis," Cancer Cell, vol. 9, no. 3, pp. 189-198, 2006.
21. C. Camps, F. M. Buffa, S. Colella et al., "Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer," Clinical Cancer Research, vol. 14, no. 5, pp. 1340-1348, 2008.
22. M. E. Crosby, R. Kulshreshtha, M. Ivan, and P. M. Glazer, "MicroRNA regulation of DNA repair gene expression in hypoxic stress," Cancer Research, vol. 69, no. 3, pp. 1221-1229, 2009.
23. X. Huang, L. Ding, K. L. Bennewith et al., "Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation," Molecular Cell, vol. 35, no. 6, pp. 856-867, 2009.
24. Z. Zhang, H. Sun, H. Dai et al., "MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT," Cell Cycle, vol. 8, no. 17, pp. 2756-2768, 2009.
25. A. M. Cheng, M. W. Byrom, J. Shelton, and L. P. Ford, "Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis," Nucleic Acids Research, vol. 33, no. 4, pp. 1290-1297, 2005.
26. P. Fasanaro, Y. DAlessandra, V. Di Stefano et al., "MicroRNA- 210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3," The Journal of Biological Chemistry, vol. 283, no. 23, pp. 15878-15883, 2008.
27. A.Giannakakis,R. Sandaltzopoulos, J. Greshock et al., "miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer," Cancer Biology and Therapy, vol. 7, no. 2, pp. 255-264, 2008.
28. S. Y. Chan, Y.-Y. Zhang, C.Hemann, C. E.Mahoney, J. L. Zweier, and J. Loscalzo, "MicroRNA-210 controls mitochondrial metabolismduring hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2," Cell Metabolism, vol. 10, no. 4, pp. 273-284, 2009.
29. Z. Chen, Y. Li, H. Zhang, P. Huang, and R. Luthra, "Hypoxiaregulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression," Oncogene, vol. 29, no. 30, pp. 4362-4368, 2010.
30. H. W. Kim, H. K. Haider, S. Jiang, and M. Ashraf, "Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2," The Journal of Biological Chemistry, vol. 284, no. 48, pp. 33161-33168, 2009.
31. H. E. Gee, C. Camps, F. M. Buffa et al., "hsa-mir-210 is amarker of tumor hypoxia and a prognostic factor in head and neck cancer," Cancer, vol. 116, no. 9, pp. 2148-2158, 2010.
32. T. Greither, L. F. Grochola, A. Udelnow, C. Lautenschläger, P. Würl, and H. Taubert, "Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival," International Journal of Cancer, vol. 126, no. 1, pp. 73- 80, 2010.
33. M. Li, X.Ma, B. Zhang, J.Huang, L. Liu, and Y.Wei, "Prognostic role of MicroRNA-210 in various carcinomas: a systematic review and meta-analysis," Disease Markers, vol. 2014, Article ID106197, 10 pages, 2014.
34. J. Wang, J. Zhao, M. Shi et al., "Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis," PLoS ONE, vol. 9, no. 2, Article ID e89223, 2014.
35. N. Sawabata, E. Miyaoka, H. Asamura et al., "Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade," Journal ofThoracic Oncology, vol. 6, no. 7, pp. 1229-1235, 2011.
36. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCR and the 2- CT method," Methods, vol. 25, no. 4, pp. 402-408, 2001.
37. P. Guan, Z. Yin, X. Li, W. Wu, and B. Zhou, "Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues," Journal of Experimental and Clinical Cancer Research, vol. 31, no. 1, article 54, 2012.
38. M. Eilertsen, S. Andersen, S. Al-Saad et al., "Positive prognostic impact of miR-210 in non-small cell lung cancer," Lung Cancer, vol. 83, no. 2, pp. 272-278, 2014.
39. M.-P. Puisségur, N. M. Mazure, T. Bertero et al., "miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity," Cell Death and Differentiation, vol. 18, no. 3, pp. 465- 478, 2011.
40. Z.-H. Li, H. Zhang, Z.-G. Yang, G.-Q.Wen, Y.-B. Cui, and G.-G. Shao, "Prognostic significance of serummicroRNA-210 levels in nonsmall-cell lung cancer," The Journal of International Medical Research, vol. 41, no. 5, pp. 1437-1444, 2013.
41. A. Qu, L. Du, Y. Yang et al., "Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer," PLoS ONE, vol. 9, no. 3, Article ID e90952, 2014.
42. S. Qiu, S. Lin, D. Hu, Y. Feng, Y. Tan, and Y. Peng, "Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients," Journal of Translational Medicine, vol. 11, no. 1, article 10, 2013.
43. R. I.McCormick, C. Blick, J. Ragoussis et al., "miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis," British Journal of Cancer, vol. 108, no. 5, pp. 1133-1142, 2013.
44. X. Chen, Y. Ba, L.Ma et al., "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases," Cell Research, vol. 18, no. 10, pp. 997-1006, 2008.
45. J.Wang, J. Chen, P.Chang et al., "MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease," Cancer Prevention Research, vol. 2, no. 9, pp. 807-813, 2009.